☆SymBiosis Capital Partners, LLC
Quality Q
0.024
AUM ($M)
53
Positions
6
Turnover
0.60
Top-10 wt
100%
Herfindahl
0.387
History (qtrs)
2
Excess Return
not eligible
AI Eval Run AI Eval
Holdings · 12 positions · portfolio value $53M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆EVMN funds › | Evommune, Inc. | HOLD | — | 55.8% | +35.8% | 29.4 | 1,280,778 | +0 | 1 | — |
| ☆IVA funds › | Inventiva S.A. | TRIM | — | 24.8% | +13.7% | 13.1 | 2,354,000 | -246,000 | 1 | — |
| ☆WVE funds › | Wave Life Sciences Ltd. | NEW | — | 10.3% | +10.3% | 5.4 | 750,000 | +750,000 | 1 | — |
| ☆RANI funds › | Rani Therapeutics Holdings, Inc. | TRIM | — | 5.1% | -2.7% | 2.7 | 3,667,585 | -2,632,415 | 1 | — |
| ☆CLNN funds › | Clene Nanomedicine Inc. | TRIM | — | 4.0% | -0.1% | 2.1 | 431,094 | -339,401 | 1 | — |
| ☆CUSIP:86889P117 funds › | Surrozen, Inc. | HOLD | — | 0.0% | +0.0% | 0.0 | 150,000 | +0 | 1 | — |
| ☆AMPG funds › | Aldeyra Therapeutics Inc | EXIT | — | 0.0% | -12.1% | 0.0 | 0 | -2,555,000 | 0 | — |
| ☆NUVB funds › | Nuvation Bio Inc | EXIT | — | 0.0% | -10.2% | 0.0 | 0 | -1,250,000 | 0 | — |
| ☆VSTM funds › | Verastem Inc | EXIT | — | 0.0% | -14.1% | 0.0 | 0 | -2,000,000 | 0 | — |
| ☆AARD funds › | Aardvark Therapeutics, Inc. | EXIT | — | 0.0% | -5.7% | 0.0 | 0 | -476,595 | 0 | — |
| ☆CUSIP:37148K209 funds › | Generation Bio Co | EXIT | — | 0.0% | -3.4% | 0.0 | 0 | -665,000 | 0 | — |
| ☆PGEN funds › | Precigen Inc | EXIT | — | 0.0% | -11.5% | 0.0 | 0 | -3,000,000 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q1 | 53 | 6 | 0.60 | 100% | 0.387 | 0.028 | — | entered |
| 2025Q4 | 109 | 11 | 0.00 | 100% | 0.123 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status